Excited to see psilocybin for MDD being flagged on this newsletter. Psychedelics hold the most promise to transform that disease IMO.
I also wrote about this space in a post for my newsletter a while back. Lots of interesting drug development efforts across psych diseases being done with psychedelics of many varieties.
Despite early setbacks from Lykos I think this field will persevere and prevail.
Excited to see psilocybin for MDD being flagged on this newsletter. Psychedelics hold the most promise to transform that disease IMO.
I also wrote about this space in a post for my newsletter a while back. Lots of interesting drug development efforts across psych diseases being done with psychedelics of many varieties.
Despite early setbacks from Lykos I think this field will persevere and prevail.
https://bigpharmasharma.substack.com/p/the-renaissance-of-psychedelics-charting?utm_source=publication-search